Back to Treatments

Treatment

Gilteritinib

1
Conditions
58
Trials
700
Participants
45%
Average Safety

Condition Evidence

Acute myeloid leukemia

58 trials · 700 participants

70% effectiveness · 45% safety
Gilteritinib | DFDA